Cancer and Infectious Diseases
Through interdisciplinary collaborations, the cluster aims at discovery and optimization of anticancer and/or antimicrobial lead compounds that combat emerging multidrug resistance. These are validated by in vitro and in vivo models. Our mission is to:
• Design peptides/peptidomimetics and small molecules that combat multidrug-resistant bacterial infections and identify novel targets
• Develop and apply cutting-edge technologies for identification of natural products with
potential as chemotherapeutic leads
• Explore and validate novel anticancer compounds and targets
- Anti-cancer research concern: Natural products, peptide probes, small molecules, assays, and expression of target proteins. (Tilhørende billede er vist nedenfor
- Antimicrobial agents comprise: Peptide-based antibiotics, fungal/plant metabolites, bacterial pumps, and expression of target proteins. (Tilhørende billede er vist nedenfor
Cluster Leader
Henrik Franzyk
Associate professor
henrik.franzyk@sund.ku.dk
Communications Representative
Dan Stærk
Professer
ds@sund.ku.dk
Core members
| Name | Title | Image |
|---|---|---|
| Fredrik Björkling | Professor |
|
| Jan Stenvang | Associate Professor |
|
| Osman Asghar Mirza | Associate Professor |
|
| Paul Robert Hansen | Associate Professor |
|